NCT06661174|Recruiting
A Cohort Study on the Efficacy of Bariatric Surgery for Rapidly Progressing Diabetic Nephropathy
EBSDKD
Loading search results
EBSDKD
Sponsor study identifier
observational
100
1 country
1
Study Start
October 1, 2023
Actual (reported)Primary Completion
October 30, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
October 30, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Establish a cohort of diabetic kidney disease(DKD) patients with intensive weight loss treatment to evaluate the impact of intensive weight loss treatment on the renal prognosis of DKD and construct a prediction model for the improvement of renal outcomes after weight loss.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 30, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 1, 2023
Actual (reported)May 22, 2024
Actual (reported)October 28, 2024
Actual (reported)October 30, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
October 30, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Total weight loss
1st, 3rd, 6th and 12th month after intervention, respectively.
Serum creatinine
1st, 3rd, 6th and 12th month after intervention, respectively.
Glomerular filtration rate
1st, 3rd, 6th and 12th month after intervention, respectively.
Fasting blood glucose
1st, 3rd, 6th and 12th month after intervention, respectively.
Average blood glucose from continuous glucose monitoring
1st, 3rd, 6th and 12th month after intervention, respectively.
Postprandial 2-hour blood glucose
1st, 3rd, 6th and 12th month after intervention, respectively.
Laparoscopic sleeve gastrectomy or laparoscopic gastric bypass based on β-cell function
Diet management，exercise，metformin，GLP-1 receptor agonists and other drugs which can lose weight.
Obese patients with DKD treated with intensive weight loss or traditional treatment
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China
Hua Meng
China-Japan Friendship Hospital
First Submitted
May 22, 2024
First Posted
October 28, 2024
Study Start
October 1, 2023
Actual (reported)Primary Completion
October 30, 2025
Estimated (date passed)YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study1
A Cohort Study on Obese Patients' Multidisciplinary Integrated Health Management
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
October 30, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
October 28, 2024
Record last verified: 2024-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: